Uvax Bio
Phase 1Uvax Bio has a safe and effective vaccine pipeline for the future, supporting health and improving human life through breakthrough proprietary technology.
Founded
2018
Focus
Vaccines
About
Uvax Bio has a safe and effective vaccine pipeline for the future, supporting health and improving human life through breakthrough proprietary technology.
Funding History
2Total raised: $23M
Series A$18MAdjuvant CapitalSep 15, 2021
Seed$5MAdjuvant CapitalAug 15, 2020
Company Info
TypePrivate
Founded2018
LocationDurham, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile